Expanded Access

The mission of the Northeast Amyotrophic Lateral Sclerosis Consortium® (NEALS) is to translate scientific advances into new treatments for people living with Amyotrophic Lateral Sclerosis (ALS). In addition to conducting clinical trials, NEALS is committed to sharing information about Expanded Access to investigational therapies.

Here you can read an article that describes Expanded Access Programs, compares them to other pathways for accessing investigational treatments, describes some of the challenges at the sponsor and site level, and lists resources that can help overcome these challenges.

Here is a series of short videos about different aspects of Expanded Access

Here you can watch longer Educational Webinars containing information about Expanded Access

Here you can see a roadmap and step by step guide to opening an Expanded Access Program at a site

Here is a list of some of the active Expanded Access Protocols. Please note that each protocol has its own list of inclusion and exclusion criteria and not every person living with ALS will qualify. If you have information about an Expanded Access Protocol not listed below, please contact Carly Allen, NEALS Communications and Outreach Manager, at callen@neals.org.

Here you can find additional resources for clinicians

 

DISCLAIMER CONCERNING INFORMATION ABOUT EXPANDED ACCESS
The information is provided “as is.” NEALS shares information concerning Expanded Access as a public service, for general information purposes only. The information is gathered from other public websites and is made available without evaluation or endorsement by NEALS. It may be incomplete, outdated, or irrelevant to a particular reader’s situation. By providing this information, NEALS is not recommending any treatment to individual patients.